Virtus ETF Advisers LLC Arvinas, Inc. Transaction History

Virtus ETF Advisers LLC

  • $206 Million
  • Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,486 shares of ARVN stock, worth $66,512. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,486
Previous 3,423 1.84%
Holding current value
$66,512
Previous $91,000 6.59%
% of portfolio
0.04%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.66 - $32.73 $1,490 - $2,061
63 Added 1.84%
3,486 $85,000
Q2 2024

Aug 14, 2024
BUY
$24.46 - $40.4 $24,264 - $40,076
992 Added 40.81%
3,423 $91,000
Q1 2024

May 15, 2024
SELL
$36.38 - $52.31 $5,966 - $8,578
-164 Reduced 6.32%
2,431 $100,000
Q4 2023

Feb 15, 2024
SELL
$14.19 - $42.33 $10,869 - $32,424
-766 Reduced 22.79%
2,595 $106,000
Q3 2023

Nov 07, 2023
SELL
$19.64 - $28.21 $6,638 - $9,534
-338 Reduced 9.14%
3,361 $66,000
Q2 2023

Aug 14, 2023
BUY
$21.73 - $31.43 $21,969 - $31,775
1,011 Added 37.61%
3,699 $91,000
Q1 2023

May 15, 2023
SELL
$26.15 - $37.26 $27,012 - $38,489
-1,033 Reduced 27.76%
2,688 $73,000
Q4 2022

Feb 14, 2023
BUY
$32.47 - $57.24 $26,657 - $46,994
821 Added 28.31%
3,721 $127,000
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $837 - $1,159
20 Added 0.69%
2,900 $129,000
Q2 2022

Aug 12, 2022
BUY
$36.01 - $74.24 $19,157 - $39,495
532 Added 22.66%
2,880 $121,000
Q1 2022

May 16, 2022
SELL
$60.27 - $81.57 $8,799 - $11,909
-146 Reduced 5.85%
2,348 $158,000
Q4 2021

Feb 14, 2022
SELL
$65.85 - $96.21 $2,370 - $3,463
-36 Reduced 1.42%
2,494 $205,000
Q3 2021

Nov 15, 2021
SELL
$73.2 - $107.87 $9,150 - $13,483
-125 Reduced 4.71%
2,530 $208,000
Q2 2021

Aug 10, 2021
SELL
$60.45 - $84.26 $150,883 - $210,312
-2,496 Reduced 48.46%
2,655 $204,000
Q1 2021

May 17, 2021
BUY
$58.19 - $91.37 $5,702 - $8,954
98 Added 1.94%
5,151 $340,000
Q4 2020

Feb 12, 2021
SELL
$20.19 - $84.93 $96,366 - $405,370
-4,773 Reduced 48.58%
5,053 $429,000
Q3 2020

Nov 13, 2020
SELL
$22.99 - $36.34 $30,714 - $48,550
-1,336 Reduced 11.97%
9,826 $232,000
Q2 2020

Aug 05, 2020
BUY
$29.88 - $56.74 $80,676 - $153,198
2,700 Added 31.91%
11,162 $374,000
Q1 2020

May 14, 2020
SELL
$33.0 - $54.5 $40,788 - $67,362
-1,236 Reduced 12.74%
8,462 $341,000
Q4 2019

Feb 13, 2020
SELL
$15.39 - $44.38 $38,567 - $111,216
-2,506 Reduced 20.53%
9,698 $398,000
Q3 2019

Nov 12, 2019
SELL
$21.55 - $27.61 $14,654 - $18,774
-680 Reduced 5.28%
12,204 $263,000
Q2 2019

Aug 13, 2019
BUY
$15.96 - $23.8 $205,628 - $306,639
12,884 New
12,884 $283,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email